tirzepatide caremark CVS will cover Lilly's weight loss drug Zepbound again after patient backlash Dr. Elizabeth Kazarian, MD |

Key takeaways A generic version of Mounjaro is not yet available and may not hit the market until at least the early 2030s, when the brand-name patent expires

This compression of review timelines means that a Paragraph IV filing and active litigation no longer provide the multi-year competitive cushion they once did simply from FDA processing delays

[1] If planning pregnancy, tirzepatide should be discontinued at least 1 month before conception, as safety data in pregnancy are limited

Tirzepatide has shown higher weight loss potential in clinical trials

Research into peptides that support gut health can identify complementary compounds that may ease the transition

The connection between sleep, stress, and GLP-1 medication effects goes beyond sulfur burps